6/4
08:04 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $73.00 price target on the stock.
Medium
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $73.00 price target on the stock.
5/23
01:00 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
5/23
01:00 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
5/14
11:30 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
5/14
11:30 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
5/9
03:39 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
4/23
08:09 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
4/17
03:01 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
4/17
03:01 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
4/17
08:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
4/17
08:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
4/16
01:18 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
4/3
07:45 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
4/3
07:27 am
legn
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $82.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $82.00 price target on the stock.
4/3
06:12 am
legn
Legend Biotech initiated with bullish view at Cantor Fitzgerald
Low
Report
Legend Biotech initiated with bullish view at Cantor Fitzgerald
4/1
08:09 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.